Longevity in Small Cell Lung Cancer
Author Information
Author(s): R.L. Souhami, K. Law
Primary Institution: University College and Middlesex School of Medicine
Hypothesis
What is the long-term survival rate of patients with small cell lung cancer (SCLC) treated in the UK?
Conclusion
Only a small proportion of patients with SCLC are cured by current treatment, with long-term survival rates remaining low.
Supporting Evidence
- Only 5.9% of patients survived 2 years or more after treatment.
- 2 year survival for patients with limited disease was 8.5%, while for extensive disease it was only 2.2%.
- Death from SCLC continued until 7 years after diagnosis, but not thereafter.
- Vascular disease and respiratory failure were common causes of death in survivors.
- Survival rates did not significantly differ based on initial disease extent, sex, or treatment type.
Takeaway
Most people with small cell lung cancer don't live very long after diagnosis, but some can survive for a couple of years with treatment.
Methodology
Data was collected from eight UK treatment centers that conducted trials from 1978 to 1986, analyzing survival rates and causes of death.
Potential Biases
Treatment assignment was not random, which may influence survival outcomes.
Limitations
The study may not account for all non-fatal illnesses and relies on available records for cause of death.
Participant Demographics
The study included 3,681 patients with varying disease extents, ages, and sexes.
Want to read the original?
Access the complete publication on the publisher's website